Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array

Xuefeng Wang, Ming Zhao, David D. Nolte, Timothy L. Ratliff

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Fluorescence-free biosensor arrays for protein detection directly measure the protein surface density, and do not require a fluorophore or enzyme label, and provide quantitative and consistent signals. However, few fluorescence-free biosensor protein arrays have demonstrated successful application in high-background samples, such as serum, due to non-specific binding. We tested the BioCD as a fluorescence-free biosensor based on optical interferometry, and used it to detect prostate specific antigen (PSA, a biomarker of prostate cancer) in patient sera in a 96-well anti-PSA microarray. We have attained a 4. ng/ml detection limit in serum and have measured PSA concentrations in patient sera. The measured concentrations correlated well with enzyme-linked immunosorbent assay (ELISA) results. The measurement of PSA concentrations in high-level protein backgrounds suggests that the BioCD has a potential for clinical applications by removing the restriction of fluorescence-free biosensors from high-background applications.

Original languageEnglish (US)
Pages (from-to)1871-1875
Number of pages5
JournalBiosensors and Bioelectronics
Issue number5
StatePublished - Jan 15 2011


  • Antibody microarray
  • BioCD
  • Cancer biomarker
  • Interferometry
  • Label-free
  • Optical biosensor
  • Prostate specific antigen
  • Serum

ASJC Scopus subject areas

  • Biotechnology
  • Biophysics
  • Biomedical Engineering
  • Electrochemistry


Dive into the research topics of 'Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array'. Together they form a unique fingerprint.

Cite this